The Right Way to Stop Taking Ozempic, Wegovy, or Mounjaro, According to Doctors Stopping GLP-1 receptor agonist medications like Ozempic, Wegovy, or Mounjaro requires careful planning and medical supervision. These …
patients
-
-
Undetected TB May Be Lurking in U.S. Hospitals, Ultrasensitive Assay Suggests – MedPage Today Ultrasensitive Molecular Test Identifies Substantial TB Underdiagnosis in Boston – Inside Precision Medicine Unexpected detection of …
-
Former UCLA Gynecologist James Heaps Pleads Guilty to Sexual Abuse Felonies A former gynecologist at the University of California, Los Angeles (UCLA) has pleaded guilty to multiple felony charges involving …
-
Fuel Prices and Supply Chain Disruptions: How New Zealand’s Primary Care is Adapting New Zealand’s primary healthcare system is currently facing a multifaceted challenge. From the soaring cost of fuel …
-
Adenoid Cystic Carcinoma: A Rare Cancer with Complexities Adenoid cystic carcinoma (ACC) is a rare and often challenging cancer that typically develops in the secretory glands, most commonly found in …
-
New CAR-T Cell Therapy Approved for Lymphoma in Spain Madrid, March 26, 2026 – The Spanish National Health System (SNS) has incorporated a new chimeric antigen receptor (CAR-T) cell therapy …
-
Health
Is Perimenopause Being Medicalized? A Critical Look at the “M Factor 2” & Women’s Health Trends
The Medicalization of Midlife: A Critical Look at the Perimenopause “Epidemic” A fresh film, “The M Factor 2: Before the Pause,” which premiered on PBS on March 19, 2026, is …
-
Fake Doctor Operating in Tuscany: Risks and Legal Consequences Authorities in Tuscany, Italy, have uncovered an illegal medical practice operated by a man of Chinese origin who posed as a …
-
Obstructive Sleep Apnea Linked to Increased Cancer Risk and Mortality, Research Suggests Novel research indicates a significant link between obstructive sleep apnea (OSA) and an increased risk of cancer, its …
-
The LaRoques’ Healthcare Empire: From Lavish Weddings to Legal Battles Over Surprise Billing A couple’s extravagant lifestyle, funded by a company navigating the complexities of out-of-network medical billing, is facing …